Fresenius Medical Care AG & Co. KGaA / Key word(s): Disposal/Investment
Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care sells Sound Inpatient Physicians Holdings for $2.15 billion
21-Apr-2018 / 14:47 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Fresenius Medical Care, the world's largest provider of dialysis products and services, today has signed a definitive agreement to divest its controlling interest in Sound Inpatient Physicians Holdings, LLC ("Sound") to an investment consortium led by Summit Partners, L.P. for total transaction proceeds of $2.15 billion (EUR 1.76 billion1). The divestment is expected to generate a pre-tax book gain of approximately EUR 800 million1,2.
In 2014, Fresenius Medical Care invested in becoming the majority shareholder in Sound, which thereafter acquired Cogent Healthcare, Inc. The investments by Fresenius Medical Care were targeted to learn about and broaden its experience in value-based care programs of those businesses. Following the successful application of this knowledge relevant for value-based programs and efficient patient coordination into Fresenius Medical Care, the Company is now in a position to divest the shareholding and free up the invested capital for further growth investments.
Closing of the transaction is subject to regulatory approvals and anticipated to occur late in 2018. The financial targets for 2018 and 2020 do not include the effects of this divesture.
______________
[1] EUR/USD 1.22
[2] based on the company's latest available valuation of the North American business segment
Fresenius Medical Care is the world's largest provider of products and services for individuals with renal diseases of which around 3.2 million patients worldwide regularly undergo dialysis treatment. Through its network of 3,752 dialysis clinics, Fresenius Medical Care provides dialysis treatments to 320,960 patients around the globe. Fresenius Medical Care is also the leading provider of dialysis products such as dialysis machines or dialyzers. Along with the core business, the company focuses on expanding the range of related medical services in the field of Care Coordination. Fresenius Medical Care is listed on the Frankfurt Stock Exchange (FME) and on the New York Stock Exchange (FMS).
For more information visit the company's website at www.freseniusmedicalcare.com.
21-Apr-2018 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de